Company / AR per Share
Halozyme AR per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest AR per Share
$3.46
FY2025
5-year range
$0.67 / $3.46
FY2021-FY2025
Trend
+52.3%
vs FY2024
Sector context
#28 of 115
Health Care
What the data says
Halozyme's ar per share of $3.46 is higher than 76% of companies in the Health Care sector (FY2025). AR per Share has increased for 4 consecutive years, from $0.67 in FY2021 to $3.46 in FY2025.
Based on SEC 10-K filings.
3.46 in FY2025 with a 5-year CAGR of +37.1%. Top quartile in the Health Care sector.
Improved from $1.73 to $3.46 over the past 2 years.
Health Care sector context is included.
AR per Share over time
Growth rates
- 3-Year CAGR
- +27.2%
- 5-Year CAGR
- +37.1%
- 10-Year CAGR
- -
Sector benchmark
Top 24% in Health CareTop 24% of 115This company $3.46 Sector average $27.05
▼
-87.2% below sector average
Key checks
Key Insights
- Halozyme's ar per share has grown for 4 consecutive years.
- In FY2025, ar per share increased 52.3% year-over-year.
- Ranks #28 out of 115 companies in the Health Care sector.
- Lowest ar per share in the period was in FY2016.
Company context
Key Data Points
- Strong profit margin: 47.9%
- High earnings quality (cash-backed earnings)
- Strong return on equity: 118.2%
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | AR per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $3.46 | +52.3% |
| FY2024 | $2.27 | +31.7% |
| FY2023 | $1.73 | +2.7% |
| FY2022 | $1.68 | +149.4% |
| FY2021 | $0.67 | -5.8% |
| FY2020 | $0.71 | +74.0% |
| FY2019 | $0.41 | +95.5% |
| FY2018 | $0.21 | +23.0% |
| FY2017 | $0.17 | +39.7% |
| FY2016 | $0.12 | -52.5% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026